Affinity Asset Advisors, LLC Cassava Sciences Inc Put Options Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$9.57 - $35.08 $13.9 Million - $50.8 Million
1,449,300 New
1,449,300 $42.7 Million
Q1 2022

May 13, 2022
SELL
$32.6 - $53.05 $11.4 Million - $18.6 Million
-350,000 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$36.77 - $90.91 $10.1 Million - $25 Million
275,000 Added 366.67%
350,000 $15.3 Million
Q3 2021

Nov 12, 2021
BUY
$41.79 - $135.3 $3.13 Million - $10.1 Million
75,000 New
75,000 $4.66 Million

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $96.6M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email